According to Grand View Research, the global clinical trial recruitment industry size was valued at USD 15.7 billion in 2021 and is expected to grow at a healthy CAGR of 6.1% during the forecast period 2022-2030. The growth of the industry is attributed to the increasing demand to enhance patient recruitment and expedite the time to market new drugs. Additionally, the adoption of AI and ML for data collection and cleaning operations is expected to minimize cost and improve patient recruitment.
